DOI: 10.1097/dss.0000000000005298 ISSN: 1076-0512

Curettage Versus Topical Treatment for Positive Superficial Margins After Mohs Surgery: A Comparative Analysis of Tumor Recurrence

Ashley Khouri, Nathanael Jensen, Tejita Agarwal, Emily Beck, Eric Millican, Payam Tristani-Firouzi
Show PDF Cite

BACKGROUND

Positive margins of squamous cell carcinoma in situ or superficial basal cell carcinoma after Mohs micrographic surgery (MMS) occur in a small but clinically significant proportion of cases, with multiple management options available.

OBJECTIVE

This study aimed to compare recurrence-free survival (RFS) across different treatment modalities for positive margins after MMS to inform clinical decision making.

METHODS

This was a retrospective cohort study of 422 patients with positive margins after MMS from 2012 to 2022. Recurrence-free survival was analyzed using Kaplan–Meier methodology. Multivariable Cox regression adjusted for age, sex, immunosuppression, tumor characteristics, and anatomic location.

RESULTS

Among 388 patients in the primary analysis (306 curettage, 82 topical treatment), 3-year RFS was 92.6% (95% CI: 89.4%–95.9%) for curettage versus 82.7% (95% CI: 73.1%–93.6%) for topical treatment ( p =.021). Topical treatment was independently associated with increased recurrence risk (adjusted hazard ratio 2.73, p =.021) after controlling for risk factors. Immunosuppression was the only other significant predictor of recurrence (adjusted hazard ratio 3.04, p = .036).

CONCLUSION

Curettage demonstrated superior 3-year RFS compared with topical treatment for positive margins after MMS, with an absolute difference of 9.9%. These findings support curettage as the preferred initial management approach for positive margins after MMS when clinically feasible.

More from our Archive